将数字步态数据与代谢学和临床数据集成,以预测帕金森病的结果
Cyril Brzenczek1, Quentin Klopfenstein1, Tom Hähnel2,3
1Biomedical Data Science Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
NPJ digital medicine
|September 6, 2024
概括
数字步行传感器和机器学习有效诊断帕金森病 (PD) 和运动障碍. 将步态数据与其他生物标志物的整合有助于检测复杂的并发症,改善患者监测和诊断.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 数据科学数据科学数据科学
背景情况:
- 帕金森病 (PD) 的诊断和管理因各种症状和并发症而复杂.
- 客观地监测PD中的运动和步行障碍对于有效的患者护理至关重要.
研究的目的:
- 评估数字步行传感器数据对监测和诊断帕金森病中运动和步行障碍的有用性.
- 评估数字步行标记与代谢学和临床数据的整合,以检测并发症,非运动性结果和疾病进展子组.
主要方法:
- 一个横截面,单心的研究,涉及162名帕金森病患者和129名对照.
- 在一次访问期间,采集使用连接到鞋上的数字传感器进行步态测量.
- 应用机器学习模型来分析步行数据和集成的多式联络数据集.
主要成果:
- 机器学习模型实现了PD与对照者的显著诊断能力 (AUC 83-92%) 和运动严重程度分类 (高达75%).
- 步态数据与代谢学和临床数据的整合提高了对幻觉等具有挑战性的并发症的预测.
- 多式联络方法证明了客观的疾病监测和诊断的潜力.
结论:
- 数字步行传感器和机器学习为客观的帕金森病诊断和监测提供了强大的工具.
- 多模式数据集成,将数字生物标志物与代谢学和临床数据相结合,改善了与PD相关的复杂问题的检测.
- 这种方法有望通过增强的诊断和监测能力来推进帕金森病的管理.
相关概念视频
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499


